Clinical Trial Update: Effect of Live Combined Bifidobacterium and Lactobacillus on Glycemic Control and Other Outcomes in Type 1 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effect of live combined Bifidobacterium and Lactobacillus on glycemic control and other outcomes in type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• live combined Bifidobacterium and Lactobacillus

Snippet

Sponsor: Shenzhen People's Hospital | Conditions: Type 1 Diabetes Mellitus, Probiotics | Phase 4 | Status: COMPLETED